METTL3-mediated m6A modification leads to the upregulation of TUG1, which interacts with YBX1 to promote the upregulation of PD-L1 and CD47 transcripts, ultimately regulating tumor immune escape (Xi et al., 2024[297]). Here, METTL3 is linked to neoplasm.